Gan & Lee Pharmaceuticals Tech Stack

Chinese insulin manufacturer expanding clinical and regulatory infrastructure globally

Pharmaceutical Manufacturing Tongzhou District, Beijing 1,001–5,000 employees Founded 1998 Public Company

Gan & Lee is a Beijing-based public pharmaceutical company focused on insulin analogs and biosimilars, now scaling U.S. and EU regulatory operations. The hiring mix is heavily research and regulatory (7 of 11 open roles) at senior and leadership levels, paired with active work on clinical trial design, CDISC standards, and regulatory submissions — indicating a shift from domestic market dominance toward systematic global market entry. Tech stack centers on SAS, R, and Python for clinical data work, alongside CDISC standards for regulatory compliance.

Tech Stack 10 technologies

Core StackSAS Python Microsoft Office Word Excel Microsoft Project PowerPoint R CDISC SDTM CDISC ADaM

What Gan & Lee Pharmaceuticals Is Building

◆Challenges

Clinical trial approval
Supporting global expansion
Budget alignment
Regulatory submissions compliance
Clinical data integration
Managing multiple projects simultaneously
Limited resources for competing priorities

▲Active Projects

Clinical trial design
Regulatory submissions
Clinical data dissemination
Regulatory strategy development for u.s. and eu markets
Policy change monitoring
Clinical study report development
Cdisc standards implementation
Efficacy/safety summary preparation
New product filings in the u.s. and eu
Establish sops for regulatory efficiency

Hiring Activity

Minimal10 roles · 0 in 30d

Department

Research

Regulatory

Data

Healthcare

Ops

Sales

Seniority

Senior

Lead

Principal

Mid

Notable leadership hires: Regulatory Affairs Director

Company intelligence

Find more companies like Gan & Lee Pharmaceuticals by tech stack, pain points and active projects

Get started free

About Gan & Lee Pharmaceuticals

Founded in 1998, Gan & Lee developed the first Chinese domestic insulin analog and is now one of China's main insulin suppliers. The company operates GMP-certified manufacturing facilities in Beijing (Tongzhou District) and Shandong (Linyi City), with a U.S. subsidiary established in New Jersey in 2014. Current clinical programs target diabetes, cardiovascular disease, metabolic disease, and oncology. The organization is actively pursuing new product filings and market authorization in North America and Europe, while managing clinical trial execution and regulatory compliance across multiple jurisdictions.

HeadquartersTongzhou District, Beijing

Company Size1,001–5,000 employees

Founded1998

Hiring MarketsChina, United States

Frequently Asked Questions

What is Gan & Lee Pharmaceuticals' main product?

Insulin analogs and biosimilars. Founded in 1998, the company developed the first Chinese domestic insulin analog and is now one of China's primary insulin suppliers, with ongoing clinical programs in cardiovascular, metabolic, and oncology areas.

Is Gan & Lee hiring in the United States?

Yes. The company has 11 active roles globally, posted across China and the United States, with openings in research (4), regulatory (3), data, healthcare, operations, and sales functions.

What tech does Gan & Lee use for clinical data?

SAS, R, Python, CDISC SDTM, and CDISC ADaM. The stack reflects focus on clinical trial data standardization and regulatory submission preparation for U.S. and EU markets.